‘The New Era of Paediatrics: Technology in Practice’

Speakers

• Dr Subarna Chakravorty, MBBS, FRCPath, MRCPCH,PhD
  Dr Subarna Chakravory is a Paediatric Haematologist with a special interest in red cell disorders. She led the Paediatric Haemoglobinopathy team at Imperial College Healthcare NHS Trust for 5 years, where she was involved in the bone marrow transplant programme for paediatric sickle cell disease and thalassaemia. Subsequently, Dr Chakravorty joint the red cell team at King’s College Hospital in July 2015.
  
  Dr Chakravorty was the Paediatric deputy lead for the National Haemoglobinopathy Peer Review for 2015-2016 and is a member of the National forum for Haemoglobin disorders. She also led the ‘Sickle Cell Early Years Theme’ of the ‘Collaboration for Leadership in Applied Health Research and Care’ (CLAHRC) in North West London and with her team developed a validated patient experience tool for Sickle Cell disease with funding from the National Institute of Health Research (NIHR) and the Roald Dahl Marvellous Children’s Charity. Dr Chakravorty is currently serving as Chair of the NHS England London Region Haemoglobinopathies Forum.
  
  She is interest in adolescent health and has been involved in a number of patient engagement projects with young people with haemoglobin disorders, which has led to the development of mobile phone ‘apps’ and self-help programmes.
  
  Dr Chakravorty is also interested in clinical and molecular research in sickle cell disease and is involved in a number of scientific projects at Imperial and King’s College London.
• Professor Neena Modi, MB ChB MD FRCP FRCPCH FFPM
  Professor Modi is Professor of Neonatal Medicine at Imperial College London. Following her qualification from the University of Edinburgh, she undertook specialist training in neonatal medicine at University College Hospital London, and the University of Liverpool. Currently, she has clinical duties as an Honorary Consultant in Neonatal Medicine based at Chelsea and Westminster NHS Foundation Trust where she is the senior consultant in a team providing neonatal services for a tertiary referral service and lead medical and surgical perinatal service for north-west London.
  
  Professor Modi was also the former RCPH President from 2015 to March 2018. She has held many other roles, including President of the UK Neonatal Society, President of the Academic Paediatrics Association of Great Britain and Ireland, chair of The British Medical Ethics committee, and Chair of the NHS England Infant, Children and Young People Patient Safety Expert Group.
  
  She led the development of the UK National Neonatal Research Database and now directs this national and international resource for research, quality improvement, audit and surveillance that contains detailed information on all admissions to neonatal units in England, Wales and Scotland. In 2007 Professor Modi led the establishment of the Neonatal Data Analysis Unit at Imperial College London, and in 2012, the UK Neonatal Collaborative, with the aim of developing the use of clinical electronic data to support neonatal services and research. During her tenure as Vice President for Research at the RCPCH, Modi was lead author on the RCPCH’s Turning the Tide report highlighting the need to strengthen child health research in the UK.
• Dr Robert Klaber, MA MBBS FRCPCH FHEA FAcadMEd MD
  Dr Klaber is a Consultant in General Paediatrics (based at the St Mary’s site) with a longstanding interest in medical education. He has worked in a number of roles across undergraduate and postgraduate medical education. Dr Klaber trained in Cambridge and London and obtained his mixed methods Md in leadership development from University College London. He has a strong interest in individual and systems learning, behavioural insights work and leadership development. He is involved with simulation work and has written and edited leadership development e-learning modules for the E-learning for Healthcare project,Lead. He is also working on projects to look at the development of a future workforce who can work and learn within integrated health care systems. In 2010 he set up the Paired Learning programme, which has now been adopted by a number of organisations across the UK.
  
  Since 2015, through his Associate Medical Director role, Bob has been leading an ambitious project to create a culture of continuous quality improvement programme across Imperial. In the Queen’s Birthday Honours List in 2018, Dr Klaber received an OBE.
  
  Dr Klaber is also a strong advocate for child health and co-leads the Connecting Care for Children (CC4C) integrated child health programme in North West London, which is focused on developing whole population integrated care models of service and training within paediatrics and child health.
• Dr E. David G. McIntosh AM, MBBS, MPH, LLM, PhD, FAFPHM, FRACP, FRCP&CH, DRCOG, DCH, Dip Pharm Med.
  Dr E. David G. McIntosh AM is an Australian paediatrician, vaccinologist and infectious disease specialist. He originally trained as a medical doctor in Sydney, Australia, and specialised in paediatric infectious diseases and public health.
  
  His early research was on early-onset Group B streptococcal in Sydney. His PhD thesis described the molecular epidemiology of hepatitis B virus in recent immigrant families to Australia. He co-authored the landmark 50-year follow-up of the original congenital rubella syndrome patients. His post-doctoral work was on gene therapy for hepatitis, in the Department of Medicine at Imperial College, London, UK.
  
  Dr McIntosh is the founder and Artistic Director of the Glebe Music Festival in Sydney, Australia, founded in 1990: www.glebemusicfestival.com. He is also an Honorary Clinical Senior Lecturer at Imperial College, London, and Honorary Professor at the Scientific Center for Children’s Health, Moscow, Russia. He is an EDC Expert. In the Queen’s Birthday Honours List in June 2011 he was appointed as a Member in the General Division of the Order of Australia, within the Australian Honours System.He completed a four-year Higher Medical Training period in Pharmaceutical Medicine at the Royal College of Physicians, London. In May 2012 he obtained another post-graduate degree, a Master’s degree in Medical Law and Ethics (LLM), the dissertation for which was on the subject of maternal immunisation.
  
  Dr McIntosh was Head, Global Scientific Affairs at Novartis Vaccines from 29^th April 2014, and Global Scientific Affairs Senior Expert there, from 1st December 2009. Prior to this, he was Medical Director Vaccines and Infectious Diseases Europe/Middle East/Africa at Wyeth Pharmaceuticals. Dr McIntosh joined Takeda Vaccines as Senior Director Policy and Scientific Affairs (Vaccines) on 1^st September 2015, and became Regional Medical Affairs Lead, Latin America, on 7^th December 2015.